Malaria vaccine implementation programme
WHO recommends the RTS,S/AS01 (RTS,S) malaria vaccine to prevent malaria in children at risk. The recommendation for the first malaria vaccine was informed by results from the ongoing pilot programme in Ghana, Kenya and Malawi. Four years on for the pilots, nearly 1.5 million children have been reached with their first dose of malaria vaccine since 2019.
Multimedia
Q&As
Malaria: The real-world impact of the first malaria vaccine in Kenya
Cette video est également disponible en version française.
Infographics
Multimedia
Video: Lifesaving malaria vaccine: harnessing innovation to fight an ancient killer
Countries
SAGE/MPAG Working Group
Technical background
This Framework is intended to be dynamic to support prioritization decisions at the start of vaccine roll-out and over the coming years as supply ramps...
External publications
(The New England Journal of Medicine, DOI: 10.1056/NEJMoa2026330, p13, 25 August 2021)
Seasonal Malaria Vaccination with or without Seasonal Malaria Chemoprevention
Seasonal Malaria Vaccination with or without Seasonal Malaria Chemoprevention
(The Lancet, Vol 386, No.9988, p31-45, 4 July 2015)
Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial
Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial
(The Lancet, Vol 387, No. 10016, p367–375, 23 January 2016)
Penny MA, et al. Public health impact and cost-effectiveness of the RTS,S/AS01 malaria vaccine: a systematic comparison of predictions from four mathematical models
Penny MA, et al. Public health impact and cost-effectiveness of the RTS,S/AS01 malaria vaccine: a systematic comparison of predictions from four mathematical models
